Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Assets (2019 - 2025)

Historic Return on Assets for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to 0.89%.

  • Dna X's Return on Assets fell 6200.0% to 0.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89%, marking a year-over-year decrease of 6200.0%. This contributed to the annual value of 0.72% for FY2024, which is 7200.0% down from last year.
  • Per Dna X's latest filing, its Return on Assets stood at 0.89% for Q3 2025, which was down 6200.0% from 0.88% recorded in Q2 2025.
  • Dna X's 5-year Return on Assets high stood at 0.01% for Q4 2023, and its period low was 0.97% during Q4 2021.
  • For the 5-year period, Dna X's Return on Assets averaged around 0.53%, with its median value being 0.66% (2021).
  • In the last 5 years, Dna X's Return on Assets skyrocketed by 8500bps in 2023 and then tumbled by -7800bps in 2024.
  • Quarter analysis of 5 years shows Dna X's Return on Assets stood at 0.97% in 2021, then skyrocketed by 71bps to 0.29% in 2022, then skyrocketed by 102bps to 0.01% in 2023, then tumbled by -13305bps to 0.77% in 2024, then dropped by -16bps to 0.89% in 2025.
  • Its last three reported values are 0.89% in Q3 2025, 0.88% for Q2 2025, and 0.82% during Q1 2025.